← All Insights
biotechAI implementationSan DiegochecklistHIPAA

AI Implementation Checklist for San Diego Biotech Companies

A practical checklist for biotech and life science companies in San Diego preparing to implement AI systems. Covers data, compliance, infrastructure, and vendor selection.

Solvren AI Team · January 5, 2025

San Diego’s biotech cluster — from Torrey Pines to Sorrento Valley — is one of the most AI-ready in the country. The data exists. The use cases are clear. The regulatory context is well-understood.

What’s missing, for most companies, is a clear starting framework for implementation.

This checklist is what we run through with every biotech client before starting any AI project.

Phase 1: Data readiness

Document inventory

  • Identify the primary document types (clinical trial data, lab reports, regulatory filings, literature)
  • Assess document format distribution (PDFs, structured databases, EHR exports, Excel)
  • Estimate volume (number of documents, update frequency)
  • Identify data owners and access controls

Data quality

  • Sample 100 documents and manually review for quality
  • Identify OCR quality issues in scanned documents
  • Assess consistency of field names and formats across document types
  • Identify any PII or PHI that requires special handling

Data infrastructure

  • Confirm cloud environment (AWS, Azure, GCP) and available services
  • Identify current data storage locations
  • Confirm backup and retention policies
  • Assess current ETL or data pipeline infrastructure

Phase 2: Compliance review

HIPAA considerations

  • Identify if any data contains PHI (Protected Health Information)
  • Confirm Business Associate Agreements with any AI vendors
  • Review data handling requirements for your specific data types
  • Confirm audit logging requirements

21 CFR Part 11 (if applicable)

  • Assess whether AI system outputs will be used in regulated activities
  • Identify electronic signature requirements
  • Plan for system validation documentation
  • Identify audit trail requirements

ITAR (if applicable)

  • Identify any defense-related research data
  • Confirm export control classification of your data
  • Assess cloud provider compliance (GovCloud requirements)

Internal compliance

  • Loop in legal/compliance team before any vendor contracts
  • Review IP ownership provisions in AI vendor agreements
  • Confirm data residency requirements

Phase 3: Use case prioritization

For each potential AI use case, score it on:

Impact (1–5): How much time or money does this save? Feasibility (1–5): How structured is the data? How clear is the task? Risk (1–5, inverted): What’s the consequence of an error?

Start with high impact + high feasibility + low risk use cases.

Common high-value biotech AI use cases:

  • Clinical trial document extraction (high feasibility — structured templates)
  • Literature review and evidence synthesis (high impact — expensive currently)
  • Regulatory document automation (high impact — time-consuming currently)
  • Lab report analysis and anomaly detection (medium — depends on data quality)
  • Drug interaction screening (medium — high accuracy requirements)

Phase 4: Infrastructure requirements

Compute

  • Assess whether you need on-premise GPU infrastructure
  • Identify cloud GPU availability in your region
  • Estimate inference cost per query at expected volume
  • Plan for scaling requirements

Security

  • Review network architecture for AI services
  • Confirm VPC/private endpoint requirements
  • Identify monitoring and alerting requirements
  • Plan for model access controls

Integration

  • Map existing systems that AI will integrate with
  • Identify API availability for each system
  • Confirm authentication and authorization patterns
  • Assess data synchronization requirements

Phase 5: Vendor selection

Questions to ask every AI vendor:

  1. Where does our data go during inference?
  2. Is our data used to train your models?
  3. Do you have a BAA (Business Associate Agreement)?
  4. What’s your SOC 2 Type II status?
  5. Can you deploy in our cloud environment?
  6. What does ongoing support look like post-deployment?
  7. Who owns the IP in outputs generated by your system?

Red flags:

  • Vague answers about data handling
  • No BAA available
  • “We’ll figure out compliance later”
  • Demo-only experience, no production deployments

Phase 6: Pilot design

A well-designed pilot:

  • Has a specific success metric defined before it starts
  • Runs for a defined time period (4–8 weeks typical)
  • Has a clear decision criterion for “go to production” vs “stop”
  • Includes IT and security from day one
  • Has a named system owner post-deployment
  • Includes budget for ongoing maintenance

If you’re working through this checklist and want expert guidance, that’s exactly what our AI Readiness Audit covers — in 2 weeks, with a written deliverable you keep.

Solvren AI is San Diego’s AI implementation agency for biotech, healthcare, and defense companies.

Get Started

Ready to move from
experiment to production?

Book a free 30-minute AI audit. We'll identify your top opportunities and tell you exactly what's possible — no pitch, just value.

No commitment. No sales pitch. Just 30 minutes with an engineer.